HomeSVE • WSE
add
Synthaverse SA
Previous close
zł 4.65
Day range
zł 4.62 - zł 4.66
Year range
zł 3.74 - zł 5.93
Market cap
305.42M PLN
Avg Volume
79.42K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 13.41M | 65.45% |
Operating expense | 8.49M | 5.39% |
Net income | -444.00K | 81.63% |
Net profit margin | -3.31 | 88.90% |
Earnings per share | — | — |
EBITDA | 2.44M | 308.10% |
Effective tax rate | 26.61% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.98M | -56.30% |
Total assets | 290.33M | 27.95% |
Total liabilities | 176.57M | 47.50% |
Total equity | 113.76M | — |
Shares outstanding | 70.27M | — |
Price to book | 2.87 | — |
Return on assets | -0.03% | — |
Return on capital | -0.04% | — |
Cash Flow
Net change in cash
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -444.00K | 81.63% |
Cash from operations | 7.28M | 822.74% |
Cash from investing | -3.11M | 91.37% |
Cash from financing | -1.92M | -106.14% |
Net change in cash | 2.24M | 138.94% |
Free cash flow | -911.62K | 97.74% |
About
Biomed-Lublin Wytwórnia Surowic i Szczepionek is a Polish pharmaceutical company operating since 1944. The company manufactures medicinal preparations. The company's headquarters is in Lublin. Wikipedia
Founded
1944
Website
Employees
239
